NDC11 72426081899
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72426-0818-99 | 72426-0818 |
| 72426-818-99 | 72426-818 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nexlizet | BEMPEDOIC ACID AND EZETIMIBE | Esperion Therapeutics, Inc. | 3fa2108c-0300-47b8-9d34-f762af7c93c6 | 2026-06-25 | Warnings, Adverse reactions | 72426-818-99 72426-818 72426081899 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.